The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

An attorney for Keith Middlebrook said they would appeal and called Magic Johnson, who testified during trial, "the biggest ...

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

Even if these healthy individuals with mild symptoms have Covid-19 or influenza, they probably wouldn’t be eligible for ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

In late December, Indiana wastewater had high levels of influenza A and RSV, or respiratory syncytial virus, and very high ...

American actor and filmmaker Mel Gibson unleashed a series of startling revelations during his appearance on The Joe Rogan Experience.

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...